
ãäžçå¥åº·è©è°äŒãæ£åŒã«ãªãªãŒã¹ãããã¹ãã€ã¯ã¿ã³ãã¯ã®ãããã¯ã¹æ³ãã®å šæã玹ä»ïŒèªç¶ææãã¯ã¯ãã³æ¥çš®åŸå ±éïŒããšãQAJFè§£æ¯ãã©ã·ã
â»äžçå¥åº·è©è°äŒâå°éå®¶ãã¡ã«ããçµç¹ââã¯ã¯ãã³æ¥çš®ãã人ã諊ããªãã§!ââãžã¥ãã£ã»ãã€ã³ãŽã£ããå士ãªã©äžäººã®å»åŠè ãšç§åŠè ãèªã£ããã®å 容ãhttps://ameblo.jp/tony-9/entry-12683011807.html
ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«
ããã«æ²èŒãããŠãããã®ã¯ã»ãšãã©ãè¬ã§ã¯ãªãè§£æ¯äœçšã®ããæ€ç©ãªã©ã§ãã©ã®ãããåãã°ããã®ãã¯æžããŠãªãã®ããããŸãããèªåã®äœè³ªã奜ã¿ã«åãããŠæ§åãèŠãªããæåããŠã¿ãŠãã ããðð«
ãŸãããããŒãã¯ç®ã«äžå ·åãåºãå Žåãããããã§ããäœã§ãåããããã°ãããšèšãäºã§ããªãããã§ãââ£ïžâïž
ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«ð«
âšâšã¹ãã€ã¯ã¿ã³ãã¯è³ªé»å®³å€âšâš
ð±ãã«ãã©ïŒãŠããã°ãµïŒãð±æŸèãð±ãšã¢ãžã³ïŒã¿ãç§æ€ç©ããã³ã¯ããŠã¡ã¢ããç§æ€ç©ïŒãð²ããŒã ïŒè¬æšã€ã³ãã»ã³ãã³ïŒãð±ã¿ã³ããã®èã®æœåºç©ðã€ãã«ã¡ã¯ãã³
âšâšã¹ãã€ã¯ã¿ã³ãã¯è³ªäžåå€âšâš
ðN-ã¢ã»ãã«ã·ã¹ãã€ã³ïŒNACïŒããðã°ã«ã¿ããªã³ãããð±ãã§ã³ãã«è¶ãð±ã¹ã¿ãŒã¢ãã¹è¶ããããð±æŸèè¶ãð±ã»ã³ããžã§ã³ãºã¯ãŒãããããããð±ã³ã³ããªãŒãªãŒããããðãã¿ãã³C
âšACE2å容äœãèªç¶ã«ä¿è·ããç©è³ªâš
ðã€ãã«ã¡ã¯ãã³ãããããããããðããããã·ã¯ãããã³ïŒäºéãå«ãïŒãð§ ã±ã«ã»ãã³ïŒäºéãå«ãïŒããããðãã£ã»ãã³
âšâšâšIL-6é»å®³å€ïŒæççå€ïŒâšâšâš
ð²ãã©ã³ãã³ã»ã³ã¹ïŒã«ã³ã©ã³ç§ã®æšããæ¡ããæš¹èïŒããããããããããããð±ã¿ã³ããã®èã®æœåºç©ããããããð±ãã©ãã¯ã¯ãã³ãããããããããð±ã¯ã«ã¯ãã³ïŒãŠã³ã³/ã¿ãŒã¡ãªãã¯ïŒããðéæ²¹ããã³ãã®ä»ã®èèªé žããããð²ã·ãã¢ã³ãããããð¿ã¢ãã²ãã³ããããããðãã£ã»ãã³ïŒãã©ããã€ãïŒãããðã±ã«ã»ãã³ïŒãã©ããã€ãïŒãããðã¬ã¹ãã©ãããŒã«ãð±ã«ããªãªã³ãããðãã¿ãã³D3ïŒãã¿ãã³Kãå«ãïŒããðäºéãããðãã°ãã·ãŠã ããããð±ãžã£ã¹ãã³ãã£ãŒããð±ãã€ãªãŒãð±ãã©ãã¯ããããŒããð±ããã¡ã°ãð±ã»ãŒãž
âšâšããŒãªã³ãèªç¶ã«é»å®³ããç©âšâš
ðã«ãã³ããðãªã¢ãã³ããããããð³ãã€ã«ã¬ã€ã³ããðãã¹ããªãžã³
âšã»ãªã³ãããã¢ãŒãŒããè§£æ¯ããæ¹æ³
ã»ãªã³ãããã¢ãŒãŒãé»å®³ããäœå ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã¬ãã«ãäžããã®ã«åœ¹ç«ã€å¯èœæ§ã®ããç©è³ªïŒ
ðµç·è¶ããð±ãžã£ã¬ã€ã¢å¡èãâïžèè»ð±å€§è±ãããããð³ãã©ã³ãã³ã»ã³ã¹ããããããðN-ã¢ã»ãã«ã·ã¹ãã€ã³ïŒNACïŒ
玹ä»ããããã®ãæåæ¹æ³å¥ã§åé¡ããŠã¿ãŸããð±âð¹ð·ð
ãªãŒã«ãã€ãã£ãŒâããããã·ã¯ãããã³(ãšã¢ã®)â飲ãã§è¯ããä»ããŠè¯ããæµžãã£ãŠè¯ããå ãã§è¯ããçãããŠè¯ãã®äºæåæã£ãè¬
âãã¿ãã³ïŒ£ãæŸèããšã¢ã®åæ§ãããã䜿ããŸãã
âããŒãé¡ãâãã°ãã·ãŠã
ð¥¢é£ãâã¿ã³ããã®èã®æœåºç©ââ¶ãããœãœã®èããã²ããããµã©ãã§é£ã¹ãå Žåãã¢ã¯æããå¿ èŠã§ããâ·ãããœãœã®èã¯ããšã³ãã€ãããã³ãªããããŒãªãŒãã®ä»£ãããšããŠäœ¿ããŸããâžãããœãœå³åã¯ãããœãœã®èãšå³åãæ··ããä¿åé£
âN-ã¢ã»ãã«ã·ã¹ãã€ã³ïŒNACïŒâã°ã«ã¿ããªã³ãå€ãåãçºã®ç©=ã°ã«ã¿ããªã³
ãã»ãããè(ç)ãããã¿ããããã人åããã£ããããã ãããããŒã¡ããããŒããã¢ãã¬ããçã¬ããŒãããŠã€ãã°ã¬ãŒããã«ãŒããçé±ãèµ€è²ããããã³ãªãŒãå°éºŠèèœããã³é µæ¯ã
âãã¿ãã³Câæé žåäœçšãæåŸ ããããã«ã¯ã1æ¥ã«çŽ83.4mgãå¿ èŠ
ã¢ã»ãã©ããããããŠã€ãã«ãŒãããã ã¡
ã¬ã¢ã³ãèµ€ããŒãã³ããªã¬ã³ãžããŒãã³ãé»ããŒãã³ããããã³ãªãŒ
âã±ã«ã»ãã³âã¿ããã®(ç¹ã«å€ç®ã«å€ã)ãããŒãã³ããªã³ãŽããµããŒã¬ã¿ã¹ããããã³ãªãŒãã¢ããã€ã€ãã¢ã¹ãã©ã¬ã¹ãã±ãããŒãæåæšå¥šé20mgïœ30mgååŸ
âãã£ã»ãã³âã€ããŽåªåããªã³ãŽããã³ãŽãŒãããŠã€ããããŠãããããçããããã ããããããé¡ããµããªæšå¥š
âã¯ã«ã¯ãã³âç§ãŠã³ã³ã«å€ãå«ãŸããŠããŠãæ¥ãŠã³ã³ãªã©ã¯ãã¯ã«ã¯ãã³ã®æåãã»ãšãã©å«ãã§ããªããã«ã¬ãŒãªã©ã®ã¿ãŒã¡ãªãã¯ã®é»è²ã®è²çŽ ã¯ãç§ãŠã³ã³ãç²æ«ã«ãããã®ãªã®ã§ãã¯ã«ã¯ãã³ãå€ãå«ãŸããŠããŸãã
ä»ãç·Žãç©ãã·ããããæŒ¬ããããããé»è²ãçè²ãããç©
ã¯ã«ã¯ãã³ãšã€ãŒã¹ãèãä¹³é žèãããã£ãºã¹èãªã©ãäžç·ã«æåãããšã匷ãæé žåäœçšãæã£ãŠããããã©ãããã¯ã«ã¯ãã³ã«å€åããããã
åç¬ã§ã¯ãäœã«åžåããã«ãããã¯ã«ã¯ãã³ãå¹çããåžåããããã«ã¯ãåµã®é»èº«ã倧è±é£åãªã©ã«è±å¯ã«å«ãŸããã¬ã·ãã³ãäžç·ã«æãããšã
âéæ²¹ããã³ãã®ä»ã®èèªé žâ
ã¿ã©ããµã±ããªãã§ãŠïŒãã©ã¡ç§ã®éïŒããµãããã·ã³ãã ãããã©ã¡ããšããªã©ã®ç²æ®»é¡
âã·ãã¢ã³âãã€ãªãŒã(ã¯ã¹ããç§ããã±ã€å±ã®èã§äž»ã«ã€ã³ãç£)
å ç±ããŠããã·ãã¢ã³ã®æåã«å€è³ªã¯ç¡ããããã·ãã¢ã³ã®å¹æã¯å€ãããŸããã
å·ããæçããæããæçãŸã§ãå¹ åºãå©çšã§ããã®ã§ã奜ããªæçã«å ããŠã¿ãŸããããã·ãã¢ã³ã®æåãäžžããšåãå ¥ãããå Žåã¯ãã·ãã¢ã³ããŠããŒã§ã®æåã®ã»ãã嫿æåãå¹ççã«æåã§ããŸãã
âã¬ã¹ãã©ãããŒã«âã¶ã©ããã¬ãŒãºã³ããããé¡ã®ç®ãã³ã³ã¢ã«å«ãŸãããå¹çãèããããµããª
âã«ããªãªã³âã·ãœããšãŽããæ¥èãããŒãã³ããããã人åããã»ãªãã¬ã¢ã³ãã»ããªããªãªãŒããªã€ã«ããã³ããããŒãºããªãŒãã«ã¢ããŒã«ããããŒãã³ããã»ãŒãžãªã©ã®ããŒãã«å«ãŸããŠããŸãã
âãã¿ãã³D3âå¡©èŸãããããã®èããããããããŸã¥ãã¯ãããããªãããŸããããããã¿ããããã«ããããããããããå¹²ããã€ã¯ã©ãããã¯ãããããããã¹ã«ãããããããããããããããã
âäºéâç¡è £ãå°éºŠéºŠèœãçãªãã¢ã€ã¹ããŒãããã³ããã³ã·ãŒã(ããŒã¡ãçš®)ããã€ã³ããããããŒã¯è©ãããŒã¯ãããŒã³ãºããã¯ã€ãããã·ã¥ã«ãŒã ãã»ãããèã
âãã°ãã·ãŠã âããªç²ã倧è±ã也湯èãããããããã®ããçŽ å¹²ãããããå¹²ããã³ãçããããããããã«ãŒãããããå¹²ãããããã®äžžå¹²ããããããŸãã¢ãŒã¢ã³ããæŸã®å®ãåå¹²å€§æ ¹ãæè±ããªã¯ã©
人äœã§ã¯çæãããŸããã
âã«ãã³âã±ãŒã«ãã·ãœãã¢ããã€ã€ããšã¢ã®ããã»ãªããããŒãã³ããããžã«ãã³ããã ãã«ãã³ã© ãã»ãª
âãªã¢ãã³âã¬ã¢ã³ããªã¬ã³ãžãã°ã¬ãŒããã«ãŒãããã«ã¬ã¢ãã
ç®ã«æåãå ¥ã£ãŠãã
âãã¹ããªãžã³âææ©é¡ã®æªçãªæå®ã®ç®ãè¢ãã¹ãžã«å€ãå«ãŸããŠããŸããç®ã现ããå»ãã§ãåžãç©ã«å ¥ãã
ç ç³ãèèã«æŒ¬ããã也ç¥ãããŠãé³ç®ããšããŠå å·¥ãã
âãžã£ã¬ã€ã¢å¡èâããããã
ðµé£²ã¿ç©âãã«ãã©âæ¥æ¬ã§ã¯ããŒããã£ãšããŠçšããããããã³ã«ãã§ã€ã³
âæŸèè¶âãŸãã«ãããã®ç²Ÿæ²¹ã«ããããŸãã«èçãç®èã®çºç¹ãªã©ã®çç¶ãèµ·ããå¯èœæ§ããããŸããã¯ãŒãã¡ãªã³ãšããè¬ãæçšãããŠããæ¹ãæŸã¢ã¬ã«ã®ãŒã®ããæ¹ãã«ãã§ã€ã³ã埮éã«å ¥ã£ãŠããçºåŠå©Šããã¯æåãé¿ããŠãã ãããæŸèè¶ã«äœ¿ãããŠãããèµ€æŸ(女æŸ)ã黿Ÿ(ç·æŸ)ããã®ã»ãäºèæŸãå€§çæŸãéæŸãççæŸãªã©ã¯æ¯æ§ã¯ãããŸãããé£åŸã«æãã®ããããã
âã¿ã³ããã®èã®æœåºç©ââ ãããœãœã³ãŒããŒãâ¡ã¿ã³ããè¶ãåŠåš äžãæä¹³äžã®å¥³æ§ã«å¥œãŸããŸãã
âãã§ã³ãã«è¶â婊人ç ãæã£ãŠããæ¹ãåŠåš äžã®æ¹ãæä¹³äžã®æ¹ãã»ãªã¢ã¬ã«ã®ãŒã®æ¹ã¯ã¯äœ¿çšãæ§ããããã«ããŠãã ããã
âã¹ã¿ãŒã¢ãã¹(å «è§)è¶âã«ã€ãã¹ããã€ãã¹ã«ã¹ããã¬ãŒããŒãã£ãŒãªã©ãšãã¬ã³ããããšé£²ã¿ããããªããŸãã
ãŸãããªã¬ã³ãžããŒã«ãã·ãã¢ã³ãšã®çžæ§ãè¯ããåŠåš äžã®æ¹ã®äœ¿çšã¯ãæ§ããã ããã
âã»ã³ããžã§ã³ãºã¯ãŒãããŒããã£ãŒâãã€ç ã粟ç¥çŸæ£ã«ã圹ç«ã€
匷åãªããŒãã§ãåçåŽåçããè¬ãšäœµçšããããšã§é節ãªå¯äœçšçç¶ãåŒãèµ·ããå¯èœæ§ããããã€ã³ãžããã«(æHIVè¬)ããžãŽãã·ã³(匷å¿è¬)ãã·ã¯ãã¹ããªã³(å ç«æå¶è¬)ãçµå£é¿åŠè¬ããªããã£ãªã³ãæçšäžã®æ¹ã¯æ§ããŠãã ãããåãåŠåš äžãŸãã¯æä¹³äžã«ã»ã³ããžã§ãŒã³ãºã¯ãŒãã䜿çšãããšãå®å šã§ã¯ãªãå¯èœæ§ããããŸãã
âã±ã«ã»ãã³âå¹çããæåããã«ã¯ãçããã®ç®ã®ãè¶ãã¹ãŒããç è¶ããŠãŒãã³è¶ãçŽ è¶ã«ãå«ãŸãã
âãã©ãã¯ã¯ãã³âãã©ãã¯ã¯ãã³ãªã€ã«
1æ¥å°ãã2æ¯ã飲ã
âã·ãã¢ã³âã³ãŒããŒãçŽ è¶ã«ãµããšå ¥ããŠã倧äžå€«ã§ãããã¢ã€ã¹ã«ãµããšãããŠãçŸå³ããé ããŸãã
âã¢ãã²ãã³âã«ã¢ããŒã«ãã£ãŒãã¢ã«ã³ãŒã«é£²æããªãã¢ã¡ãŒãã«å«ãŸããŠããŸãã
âã¬ã¹ãã©ãããŒã«âèµ€ãããŠãåæã«äœãããèµ€ã¯ã€ã³ãã¶ã©ããžã¥ãŒã¹
匷åãªæé žåäœçšã§æªçã³ã¬ã¹ãããŒã«ã®é žåãé²ããåè硬åã®é²è¡ãé²ãã®ã§ã¯ãªãããšèããããŠããŸãã
âã«ããªãªã³âã«ã¢ããŒã«ãã£ãŒãã«ã¢ããŒã«ã®è±èªäœã«ã¯ã«ãã§ã€ã³ãå«ãŸããŠããªã
âäºéâã³ã³ã¢
âãžã£ã¹ãã³ãã£ãŒ
âã»ãŒãžãã£ãŒâåŠåš ã»æä¹³äžã®æ¹ãçºç±æãé«è¡å§ã®æ¹ããŠãããã®ããæ¹ã¯äœ¿çšãæ§ãããå»åž«ã«çžè«ããŠãã ããã
âã«ãã³â玫èãžã¥ãŒã¹ããã³ããã£ãŒ
âãã¹ããªãžã³âã·ãŒã¯ã®ãŒãµãŒè¶
âç·è¶
ð§éŠèŸæâãã§ã³ãã«ïŒã¹ã€ãŒããã§ã³ãã«ããã£ãšãè¬å¹ãããïŒâã¹ãŒããŒã§ã¹ãã€ã¹ãšããŠå£²ãããŠããéŠèŸæãããŒãã婊人ç ãæã£ãŠããæ¹ãåŠåš äžã®æ¹ãæä¹³äžã®æ¹ãã»ãªã¢ã¬ã«ã®ãŒã®æ¹ã¯ã¯äœ¿çšãæ§ããããã«ããŠãã ããã
âã¹ã¿ãŒã¢ãã¹ïŒå «è§ïŒâã³ãªã¢ã³ããŒãã·ãã¢ã³ãã«ã«ãã¢ã³ãã¯ããŒãïŒãã§ãŠã³ãŠïŒãªã©ãšçžæ§ãè¯ããæ¥æ¬ã¹ã¿ãŒã¢ãã¹ã¯ç¥çµæ¯ãå«ãã§ãããå¿ ãäžåœç£ãã
âãã©ãã¯ããããŒãâããã¡ã°ãâã»ãŒãž
ðãµããªâãšã¢ãžã³ãçè¬ã«å«æãããŠããå ŽåããããäžåœäŒçµ±è¬ã
âã€ãã«ã¡ã¯ãã³ã«ã€ããŠã
https://www.aboutnursingschools.com/ivermectin-dose/
âN-ã¢ã»ãã«ã·ã¹ãã€ã³(NAC)
æåé500~6000ããªã°ã©ã ãã»ã¬ã³å ¥ã®ãã®ã¯ã»ã¬ã³ã®æåéã«æ³šæã
âã»ã³ããžã§ã³ãºã¯ãŒã
å¿ ãæåäžã®è¬ãšã®é£²ã¿åããã確èªããŠãã ãããåŠåš äžãŸãã¯æä¹³äžã¯å®å šã§ã¯ãªãå¯èœæ§
âããããã·ã¯ãããã³
é倧ãªå¯äœçšã¯å°ãªããèŠåã®äœäžã倱æ
âãã£ã»ãã³
âéæ²¹ããã³ãã®ä»ã®èèªé ž
ãã£ãã·ã¥ãªã€ã«ãDHAãEPAãªã©ã®ãªã¡ã¬3ãè±å¯ã«å«ãŸããŠããèèªæ²¹ã®ããšã
éæ²¹äžã®ãªã¡ã¬3èèªé žã¯ããã³ãµãããµãšã³é žïŒDHAïŒãšãšã€ã³ãµãã³ã¿ãšã³é žïŒEPAïŒã§ãã DHAãšEPAã¯ããæçãªèèªé žã§ãã
âã¬ã¹ãã©ãããŒã«
ãã¿ãã³Cããã¿ãã³Eãšçžæ§ãè¯ããšããããŠããŸãã
åŠåš äžãæä¹³äžã¯ããªã±ãŒããªææãªã®ã§ããµããªã¡ã³ããå©çšããæ¹ã¯å¿µã®ããå»åž«ã«çžè«ããŠãã ããã
ä¹³ãããåå®®ãããåå®®çè «ãªã©å¥³æ§ãã«ã¢ã³ã®åœ±é¿ãåããç æ°ãæ£ã£ãŠããæ¹ã¯å©çšããããšãåºæ¥ãŸãããæååºè¬ãæè¡å°æ¿è¬ãªã©ãšã®çžæ§ã¯æªããšèããããŠããŸãã
âäºéâãµããªã¡ã³ãã§æããããŠããŸããšãããã©ã«ã§ãããé ãããéãã®åžåãããŸãããããŠãè²§è¡ãç¥çµé害ãªã©ãåŒãèµ·ããããšããããŸããåŠå©Šããã¯æ³šæã
âãã€ã«ã¬ã³
âèè»âã¯ãã¬ã©ãšã¹ãã«ãªã
Dr. Judy Mikovitsã«ããã°
ãã¯ããžã§ããŒã«âACE2ãžã®çµåã鲿¢ããããšã®ããšã
âãã¯ããžã§ããŒã«ã«ã€ããŠã
ãã©ã³ã¹æµ·å²žæŸæš¹ç®æœåºç©ïŒ
ããã¯ããžã§ããŒã«ããšããŠç»é²ååå
ð±çްèã®åçãè€è£œãä¿ãã
ð±ããŒãããã®ç®ããããŠã®çš®ãããŒãŒã«ãããã®æ®»ã«ãèŠãããæå¹æåãå«ãã§ããŸãã
ãå»åž«ã«çžè«
åŠåš äžãããã¯æä¹³äž
èªå·±å ç«ç¶æ
åºè¡
èèçŸæ£
å¿èçŸæ£
è¡æ¶²ãè¡ç®¡ã®ã€ãŸãã«åœ±é¿ããè¬ãããŒãããµããªã¡ã³ããªã©
ä»
èªå·±å ç«~ã¯æ¥çš®åŸã®ç¶æ ãªã®ã§æ¥çš®åã®äººã飲ããšè¯ãããâŠã
ðãšã¹ãâããŒã âè¬å¹ããŒããã¢ãŒãŠã«ããŒããšããããäŒæ¿å»åŠã®éèŠãªåææ
âãã©ã³ãã³ã»ã³ã¹âãéŠããšãã»ã³ã·ã£ã«ãªã€ã«ãªã©ã¢ãã
âãã©ãã¯ã¯ãã³ãªã€ã«âä»ã®ãªã€ã«ã«æ··ããããã¯ãªãŒã ãªã©ã«æ··ããŠããã§ã€ã·ã£ã«ãããã£ãŒã«å©çšã§ããŸããã·ã£ã³ããŒåŸã髪ã®ã»ããæã«ãå°éãé ç®ã«ãã¿èŸŒãããã«ããŠãããµãŒãžããã€ã«ãªã€ã«ãšããŠäœ¿çš
âãªã¢ãã³âææ©é¡ã®ç®ã«ããããå«ãŸããŠãã粟油æå
ð·ð·ð·ð·ð·ð·ð·ð·ð·ð·ð·ð·ð·
ãã¯ã¯ãã³ã®è§£æ¯ã«ã€ããŠã
人é¡åã®mRNAã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã¯å ç«ãäžããåãããããŸãã®ã§è§£æ¯ããã€ã€å ç«ãäžããããšãä»ã§ããäºã§ãã
mRNAã¯ãã£ãããããšæ¯ç©ã§ãäœã®äžã«å ¥ããšè¡æ ãåºæ¥ãäºãç¹åŸŽã®ããã§ãã
https://covid-vaccine.jp/pfizer-medi
åœã¯ã³ãããŠã€ã«ã¹ã¯ãããšèšãåæã§ã¯ã¯ãã³ãæã£ãŠããŸããã³ããã®ååšèšŒæã¯æªã ã«åºæ¥ãŠããŸããã
ã§ã¯ãã¯ã¯ãã³ã«ã¯äœãå ¥ã£ãŠããã®ã?mRNAãééå±ãçã®è¡ãåç©ã®æ»éªžãçºã¬ã³æ§ç©è³ªã蟲è¬ã人éã®äžçµ¶ããèµ€ã¡ãããæ¶²äœè¥æãããŠé žãããªãŠã ãç§åŠæ®çç©çãªã©ã仿²¢å±±ããã£!ãšæããã®ãå ¥ã£ãŠããŸãã人å£åæžã¯ã¯ãã³ãªã®ã§ãð±
ååšèšŒæãåºæ¥ãªããŠã€ã«ã¹ã沢山ãããŸãã
ãããŠåœã¯ã¯ã¯ãã³è§£æ¯ã®ç ç©¶çã¯ããªãã§ãããããªã®ã§æããããè§£æ¯ã«ããç©ãšãããæ€ç©ãªã©ãšç §ããåããæå¿ã®æ¹ã ã广ãèª¿ã¹æ å ±ãæ¡æ£ããŠããŸããæé²ãšèšã£ãŠã¯ã¯ãã³æ¥çš®è ããå¯äœçšãè²°ãããšãããã®ã§å šãŠã®æ¹ã«ç¥ã£ãŠæ¬²ããæ å ±ã§ãã
https://social-problem.com/vaccine-shedding/
äžã®è¡šã®ä»ã«ããããããããšæããŸããåãäœã«åã£ãŠããåã£ãŠããªããå³ã®å¥œã¿çããããã詊ããã ããðð«
çŸåš5æ³ããã¯ã¯ãã³æ¥çš®ãããŠããŸããããåæ§ã飲ã¿ããããã®ã¯ãããœãœè¶(ããããªãè¶ã®å³)ãéæ¹æ°Ž(500mlã«å€§ããäžæ¯çšåºŠãå³ã¯å°ãããã£ã±ã)ãç(å³ãªã)ããªã¹ã¹ã¡ã§ãã
æŸèã¯èµ€æŸãã«ã©ããã®ã¹ã©ãã³ãšããç©è³ªãè¯ãã®ã§ããã¹ã©ãã³ã¯ãã³ã¯ãžã§ããŒã«ãšãããµããªã«ãªã£ãŠå£²ã£ãŠããŸãã
ã¹ã©ãã³ãå°ãªããŠãæŸèå¹æã¯æããäŒããããŠããã¿ããã§ãæŸèè¶ãæŸèã¿ãã³ãæŸèã®ãéŠãæŸèãžã¥ãŒã¹ãæŸèé çã«å å·¥ããŠæ¥œãã¿ãªããè§£æ¯ããæ¹ãå¢ããŠããŸãã
ãã°ãã·ãŠã ã¯ãã«ããããèäžã«ãããããå¡©åãã°ãã·ãŠã ãæ°Žã§åéç ®æº¶ãããŠã¹ãã¬ãŒã«ããŸãã¯ã颚åã«å ¥ããŠ(ãšããœã ãœã«ã)ãã ããã
éèã®èã§ã¯ãšã¢ã®ãã»ã€ãã«ã¢ã¯ãããœãŠã广ããããŸãããšã¢ã®ã¯ãè¶ãåèåç工倫ããŠãã ãããã»ã€ãã«ã¢ã¯ãããœãŠã¯ä¹Ÿç¥ãããŠã颚åã«å ¥ããŸãã2ã3æ¥åŸãæã广ãããããã§ãã
ãšã¢ã®ã¯ä»ãåãé ã§ããå·åãåºæ¥ãŸãããªã€ã«ãããŒã ã«å å·¥ããŠäžå¹Žäžäœ¿ã£ãŠäžãã
çé ããã€ãŸããããäœããããªã©ããªã¹ã¹ã¡ã§ãã
æ®æ®µããã®é£ç掻ã§ç¡æ·»å ãç¡èŸ²è¬ãæèããŠã¹ãã¬ã¹ãæºããã€ãã€ããšç掻ããã®ã¯1çªã§ãã
ããã§ãäœãããã®å¯äœçšãåºãå Žåãäžé±éçšåºŠã®çµ¶é£ã广çã§ããæ¶åã«ããªããšãã«ã®ãŒãåãããããã§ããåç©ã¯å ·åãæªãæçµ¶é£ã§éãããŸãã
ãšã«ãã調ã¹ãŠè§£æ¯ããŠç¡äºã«ããããŠãã ããð
